Headquarters: Hartum 19 , Har Hotzvim Industrial Park Jerusalem 9777518 Israel

Investor Relations:


Most women suffer from vaginitis at least once in their lifetime; however 50% of first clinic visits end with misdiagnosis, Driven by the belief that women’s diagnosis should be faster, more accurate, and accessible to all, we developed Gyni , a platform that redefines the diagnosis of vaginitis. We started commercializing Gyni in Europe & Israel.


Medical Devices

Year Founded




Chief Executive Officer

Nimrod Lev

Chairman of the Board

Meny Lev Sagie

Chief Financial Officer

Insider Ownership

Key Investors

Employee Count


Most Recent Raise (Date)


Most Recent Round

We entered a $ 5 M round recently.

Total Capital Raised


Investment Bankers

Law Firms

Matry, Meiri & Wacht

In the CEOs Own Words

Corporate Mission

Bring better diagnostic solutions that will improve women’s health, and become a world leader.

Proudest Accomplishment

Next Milestone

AMAR clearance, Pilot studies in Israeli HMOs & IDF. Commercialization.

Geographic Markets Served

AMAR clearance, Pilot studies in Israeli HMOs & IDF. Commercialization.

Growth Drivers

Awareness to women's health. Huge market that is looking for solutions.

Growth Headwinds

Local regulation and reimbursement terms slow us while entering new markets.

Indicia of Customer Satisfaction


We can scale up production quickly, since we are working with external subcontractors who does the production.


Focus of Recruitment

Research and Development

We have several projects, supported with IP, in our pipeline.

Patent Count

Gyni - In-clinic sample collector and scanner Patent Granted in USA, Israel & JP (11,346,850 / 253067 / 7187552 ) Pending (EU, CN) GYNI Home Patent Granted (USA 11,454,576) Pending multi national (EU, JP, CN, IN) Algorithms - un-patented to keep source code as exclusive company know-how. Proprietary DATA BASE of classified vaginitis images. GYNI™ – Trade Mark. (Cleared- USA, Europe, Switzerland).

Economic Sensitivity

GYNI is aimed for developed countries. Understanding that there's a need in developing regions, as well, we have GYNI ECO concept that will allow sales in low- income countries.

Unique Metrics

Greatest Concern

Company Reports and Communications

Company Press Releases

Solution Nation Reports

Solution Nation Podcasts

Open Questions to Management